Making Pediatric Leukemia Testing Accessible - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Making Pediatric Leukemia Testing Accessible

  • By

  • Helen Bristow

  • November 18, 2026

  • 3 min

Share

  • 1

    Pediatric leukemia molecular testing often requires multiple costly, time-consuming assays and substantial infrastructure and expertise.

  • 2

    These testing requirements can limit comprehensive diagnostics in low-resource settings, including low- and middle-income countries.

  • 3

    The researchers used long-read nanopore sequencing to generate multimodal leukemia diagnostic data with a low-cost, portable platform.

  • 4

    The MinION platform can multiplex up to 12 samples per flow cell, with estimated consumables costs of about $100 per case.

  • 5

    Further validation is underway to assess concordance, or noninferiority, with standard-of-care diagnostics before broader adoption.

Original Source(s)

Related Content